Laboratoire de Chimie de Coordination UPR 8241


Accueil

Francoise BENOIT-VICAL
DR
0561175823
IPBS A-1B

Publications


2021

Amrane, D., Arnold, C. - S., Hutter, S., Sanz-Serrano, J., Collia, M., Azqueta, A., Paloque, L., Cohen, A., Amanzougaghene, N., Tajeri, S., Franetich, J. - F., Mazier, D., Benoit-Vical, F., Verhaeghe, P., Azas, N., Vanelle, P., Botté, C., & Primas, N. (2021). 2-phenoxy-3-trichloromethylquinoxalines are antiplasmodial aerivatives with activity against the apicoplast of Plasmodium falciparum. Pharmaceuticals, 14(8), 724/1–24.
Bosson-Vanga, H., Primas, N., Franetich, J. - F., Lavazec, C., Gomez, L., Ashraf, K., Tefit, M., Soulard, V., Dereuddre-Bosquet, N., Le Grand, R., Donnette, M., Mustière, R., Amanzougaghene, N., Tajeri, S., Suzanne, P., Malzert-Fréon, A., Rault, S., Vanelle, P., Hutter, S., Cohen, A., Snounou, G., Roques, P., Azas, N., Lagardère, P., Lisowski, V., Masurier, N., Nguyen, M., Paloque, L., Benoit-Vical, F., Verhaeghe, P., et al. (2021). A new thienopyrimidinone chemotype shows multistage activity against Plasmodium falciparum, including artemisinin-resistant parasites. Microbiol. Spectrum, 9(2), e00274–21/1–19.
Egwu, C. O., Tsamesidis, I., Pério, P., Augereau, J. - M., Benoit-Vical, F., & Reybier, K. (2021). Superoxide: A major role in the mechanism of action of essential antimalarial drugs. Free Radical Biol. Med., 167, 271–275.
Ouji, M., Nguyen, M., Mustière, R., Jimenez, T., Augereau, J. - M., Benoit-Vical, F., & Deraeve, C. (2021). Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites. Bioorg. Med. Chem. Lett., 39, 127884/1–6.

2020

Ouji, M., Barnoin, G., Fernández Alvarez, A., Augereau, J. - M., Hemmert, C., Benoit-Vical, F., & Gornitzka, H. (2020). Hybrid gold(I) NHC-artemether complexes to target falciparum malaria parasites. Molecules, 25(12), 2817/1–20.
Ouji, M., Bourgeade Delmas, S., Fernandez Alvarez, A., Augereau, J. - M., Valentin, A., Hemmert, C., Gornitzka, H., & Benoit-Vical, F. (2020). Design, synthesis and efficacy of hybrid triclosan-gold based molecules on Artemisinin-resistant Plasmodium falciparum and Leishmania infantum parasites. ChemistrySelect, 5(2), 619–625.
Reyser, T., Paloque, L., Ouji, M., Nguyen, M., Ménard, S., Witkowski, B., Augereau, J. - M., & Benoit-Vical, F. (2020). Identification of compounds active against quiescent artemisinin-resistant Plasmodium falciparum parasites via the quiescent-stage survival assay (QSA). J. Antimicrob. Chemother., 75(10), 2826–2834.
Reyser, T., To, T. H., Egwu, C., Paloque, L., Nguyen, M., Hamouy, A., Stigliani, J. - L., Bijani, C., Augereau, J. - M., Joly, J. - P., Portela, J., Havot, J., Marque, S. R. A., Boissier, J., Robert, A., Benoit-Vical, F., & Audran, G. (2020). Alkoxyamines designed as potential drugs against Plasmodium and Schistosoma parasites. Molecules, 25(17), 3838/1–23.
Tsamesidis, I., Egwu, O. C., Pério, P., Augereau, J. - M., Benoit-Vical, F., & Reybier, K. (2020). An LC–MS assay to measure superoxide radicals and hydrogen peroxide in the blood system. Metabolites, 10(5), 175/1–11.

2019

Robert, A., Benoit-Vical, F., Liu, Y., & Meunier, B. (2019). Small Molecules: The Past or The Future in Drug Innovation? In P. L. Carver (Ed.), (pp. 17–48). Essential Metals in Medicine: Therapeutic Use and Toxicity of Metal Ions in the Clinic, 19. Berlin, Boston: De Gruyter.